MTOR and clear cell renal carcinoma: The mTOR missense mutations are found in a wide variety of malignancies, most notably in roughly 7.5% of lung adenocarcinomas, 6% of clear cell renal cell carcinomas, 5% of endometrial carcinomas, and 4% of colorectal carcinomas (33).